[The effect of amlodipine on structure and function of the heart and exercise tolerance in patients with hypertension]

Area of Science:

• Cardiology
• Pharmacology
• Hypertension Research

Background:

• Hypertension is a major risk factor for cardiovascular disease, often leading to left ventricular hypertrophy (LVH) and diastolic dysfunction.
• Amlodipine is a widely used calcium channel blocker for hypertension management.
• The impact of amlodipine on cardiac structure and function, beyond blood pressure reduction, requires further investigation.

Purpose of the Study:

• To evaluate if amlodipine's hypotensive effect correlates with regression of left ventricular hypertrophy (LVH).
• To determine amlodipine's influence on impaired left ventricular (LV) or right ventricular (RV) diastolic function.
• To assess amlodipine's effect on exercise tolerance in hypertensive patients.

Main Methods:

• 24 mild-to-moderate hypertensive patients received amlodipine for 9 months.
• Left ventricular structure, systolic and diastolic function, and RV diastolic function were assessed at baseline and 3, 6, and 9 months.
• Incremental treadmill exercise testing was performed to evaluate exercise tolerance.

Main Results:

• Amlodipine therapy did not significantly alter left ventricular mass (LVM) or LV/RV diastolic function parameters.
• Significant improvements were observed in total exercise time (p < 0.05) and total workload (METs) (p < 0.01).
• Amlodipine led to a decrease in diastolic blood pressure during exercise testing.

Conclusions:

• Nine months of amlodipine therapy significantly enhanced exercise tolerance in hypertensive patients.
• No significant changes in LV structure or diastolic function were noted during the study period.
• Amlodipine may inhibit the progression of structural and functional cardiac abnormalities in hypertensive individuals.